Hydrocodone Extended-Release Capsules and Sofosbuvir and velpatasvir
Determining the interaction of Hydrocodone Extended-Release Capsules and Sofosbuvir and velpatasvir and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
Generic Name: sofosbuvir / velpatasvir
Brand name: Epclusa
Synonyms: Sofosbuvir and Velpatasvir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydrocodone Extended-Release Capsules-Sofosbuvir Tablets
- Hydrocodone Extended-Release Capsules-Sofosbuvir, velpatasvir, and voxilaprevir
- Hydrocodone Extended-Release Capsules-Sojourn
- Hydrocodone Extended-Release Capsules-Sojourn Inhalant
- Hydrocodone Extended-Release Capsules-Solage
- Hydrocodone Extended-Release Capsules-Solage Topical
- Sofosbuvir and velpatasvir-Hydrocodone Extended-Release Tablets
- Sofosbuvir and velpatasvir-Hydrocodone Polistirex and Chlorpheniramine Polistirex Suspension
- Sofosbuvir and velpatasvir-Hydrocodone, Chlorpheniramine, and Pseudoephedrine
- Sofosbuvir and velpatasvir-Hydrocodone, Pseudoephedrine, and Guaifenesin
- Sofosbuvir and velpatasvir-Hydrocortisone
- Sofosbuvir and velpatasvir-Hydrocortisone (Systemic)